BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29705686)

  • 1. Addiction vulnerability trait impacts complex movement control: Evidence from sign-trackers.
    Kucinski A; Lustig C; Sarter M
    Behav Brain Res; 2018 Sep; 350():139-148. PubMed ID: 29705686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basal forebrain chemogenetic inhibition disrupts the superior complex movement control of goal-tracking rats.
    Kucinski A; Kim Y; Sarter M
    Behav Neurosci; 2019 Feb; 133(1):121-134. PubMed ID: 30688488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diverse Roads to Relapse: A Discriminative Cue Signaling Cocaine Availability Is More Effective in Renewing Cocaine Seeking in Goal Trackers Than Sign Trackers and Depends on Basal Forebrain Cholinergic Activity.
    Pitchers KK; Phillips KB; Jones JL; Robinson TE; Sarter M
    J Neurosci; 2017 Jul; 37(30):7198-7208. PubMed ID: 28659281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unresponsive Choline Transporter as a Trait Neuromarker and a Causal Mediator of Bottom-Up Attentional Biases.
    Koshy Cherian A; Kucinski A; Pitchers K; Yegla B; Parikh V; Kim Y; Valuskova P; Gurnani S; Lindsley CW; Blakely RD; Sarter M
    J Neurosci; 2017 Mar; 37(11):2947-2959. PubMed ID: 28193693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal Forebrain Chemogenetic Inhibition Converts the Attentional Control Mode of Goal-Trackers to That of Sign-Trackers.
    Kucinski A; Avila C; Sarter M
    eNeuro; 2022; 9(6):. PubMed ID: 36635246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuro-Immune Modulation of Cholinergic Signaling in an Addiction Vulnerability Trait.
    Carmon H; Haley EC; Parikh V; Tronson NC; Sarter M
    eNeuro; 2023 Mar; 10(3):. PubMed ID: 36810148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addiction vulnerability and the processing of significant cues: Sign-, but not goal-, tracker perceptual sensitivity relies on cue salience.
    Phillips KB; Sarter M
    Behav Neurosci; 2020 Apr; 134(2):133-143. PubMed ID: 31916796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neuroscience of cognitive-motivational styles: Sign- and goal-trackers as animal models.
    Sarter M; Phillips KB
    Behav Neurosci; 2018 Feb; 132(1):1-12. PubMed ID: 29355335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinergic control over attention in rats prone to attribute incentive salience to reward cues.
    Paolone G; Angelakos CC; Meyer PJ; Robinson TE; Sarter M
    J Neurosci; 2013 May; 33(19):8321-35. PubMed ID: 23658172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of falls in a rat model of PD falls by the M1 PAM TAK-071.
    Kucinski A; Sarter M
    Psychopharmacology (Berl); 2021 Jul; 238(7):1953-1964. PubMed ID: 33735392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex Movement Control in a Rat Model of Parkinsonian Falls: Bidirectional Control by Striatal Cholinergic Interneurons.
    Avila C; Kucinski A; Sarter M
    J Neurosci; 2020 Jul; 40(31):6049-6067. PubMed ID: 32554512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-treatment with rivastigmine and idalopirdine reduces the propensity for falls in a rat model of falls in Parkinson's disease.
    Koshy Cherian A; Kucinski A; Wu R; de Jong IEM; Sarter M
    Psychopharmacology (Berl); 2019 Jun; 236(6):1701-1715. PubMed ID: 30607479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sign tracking predicts cue-induced but not drug-primed reinstatement to methamphetamine seeking in rats: Effects of oxytocin treatment.
    Everett NA; Carey HA; Cornish JL; Baracz SJ
    J Psychopharmacol; 2020 Nov; 34(11):1271-1279. PubMed ID: 33081558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling fall propensity in Parkinson's disease: deficits in the attentional control of complex movements in rats with cortical-cholinergic and striatal-dopaminergic deafferentation.
    Kucinski A; Paolone G; Bradshaw M; Albin RL; Sarter M
    J Neurosci; 2013 Oct; 33(42):16522-39. PubMed ID: 24133257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hot 'n' cold of cue-induced drug relapse.
    Pitchers KK; Sarter M; Robinson TE
    Learn Mem; 2018 Sep; 25(9):474-480. PubMed ID: 30115769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Hot' vs. 'cold' behavioural-cognitive styles: motivational-dopaminergic vs. cognitive-cholinergic processing of a Pavlovian cocaine cue in sign- and goal-tracking rats.
    Pitchers KK; Kane LF; Kim Y; Robinson TE; Sarter M
    Eur J Neurosci; 2017 Dec; 46(11):2768-2781. PubMed ID: 29044780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing falls in Parkinson's disease: interactions between donepezil and the 5-HT
    Kucinski A; de Jong IE; Sarter M
    Eur J Neurosci; 2017 Jan; 45(2):217-231. PubMed ID: 27469080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortico-striatal action control inherent of opponent cognitive-motivational styles.
    Avila C; Sarter M
    bioRxiv; 2024 Jun; ():. PubMed ID: 38559086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Less is more: prolonged intermittent access cocaine self-administration produces incentive-sensitization and addiction-like behavior.
    Kawa AB; Bentzley BS; Robinson TE
    Psychopharmacology (Berl); 2016 Oct; 233(19-20):3587-602. PubMed ID: 27481050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling Parkinson's disease falls associated with brainstem cholinergic systems decline.
    Kucinski A; Sarter M
    Behav Neurosci; 2015 Apr; 129(2):96-104. PubMed ID: 25798629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.